Research & Development



  不大功夫,山村就有裊裊的炊煙升起。   兒子死定了!在线自拍在线2018偷拍   再過三天,全長安的人都會知道,不出十天……全上林苑的人也就知道了。久久爱免费视频在线观看   “我睡覺的時候啊,馬車卻是要出去巡游的。”   獄卒連猶豫一下的意思都沒有,進去之後就一刀斬下了銀屏的頭顱。久久爱视频   扶荔宮的大殿,原本是雲瑯的點將廳,現在,則是劉徹辦公的地方。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo